Lyon, France

Abdelhamid Elaissari

This inventor holds 10 USPTO granted patents and 3 EPO patents. Top assignees: Biomerieux, Inc., Centre National De La Recherche Scientifique. Active years: 2000-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Abdelhamid Elaissari. Retrieved from https://idiyas.com/inventor/abdelhamid-elaissari

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 80.0

 

Average Co-Inventor Count = 4.8

ph-index = 7

Forward Citations = 246(Granted Patents)


Location History:

  • Saint Genis Laval, FR (2007)
  • Lyons, FR (2000 - 2012)

Company Filing History:


Years Active: 2000-2012

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Inventor Abdelhamid Elaissari

Introduction: Abdelhamid Elaissari is a renowned inventor based in Lyons, France, known for his groundbreaking contributions to the field of nanotechnology and drug delivery systems.

Latest Patents: Elaissari holds several patents related to innovative methods of encapsulating active ingredients for targeted drug delivery, as well as patents for novel nanomaterials with applications in various industries.

Career Highlights: With a distinguished career spanning over three decades, Elaissari has held key research positions at leading institutions in France, where he has spearheaded numerous projects focusing on nanomedicine and polymer science. His work has been instrumental in advancing the development of more effective and targeted drug delivery systems.

Collaborations: Throughout his career, Elaissari has collaborated with top researchers, pharmaceutical companies, and academic institutions worldwide to further explore the potential of nanotechnology in healthcare and other industries. His collaborative efforts have resulted in significant advancements in the field.

Conclusion: Abdelhamid Elaissari's innovative work in nanotechnology and drug delivery systems has not only earned him international recognition but has also paved the way for future advancements in targeted therapies and nanomedicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…